{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:59:26Z","timestamp":1784908766879,"version":"3.55.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Syphilis rates have been increasing in the US for the past decade. The incidence of the Jarisch-Herxheimer reaction (JHR) after penicillin treatment for early syphilis is reported to range from 8% to 56%.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To prospectively assess the incidence of JHR signs and symptoms among adults with early syphilis treated with benzathine penicillin G and to document factors associated with JHR and benzathine penicillin G treatment response outcomes.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The main study was designed as a phase 4 randomized clinical trial to compare the treatment efficacy of 1 vs 3 doses of benzathine penicillin G in adults with early syphilis, measured as serologic response at 6 months. A total of 249 adults with or without HIV were screened and enrolled between October 31, 2018, and March 3, 2020. Participants were screened and enrolled at 10 US study sites in the Sexually Transmitted Infections Clinical Trials Group. Statistical analysis for this secondary analysis took place between March 2023 and August 2024.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Participants received a first dose of benzathine penicillin G, 2.4 million units intramuscularly, at the enrollment visit. The JHR assessment window was day 1 to day 7 after the first dose of benzathine penicillin G.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Primary outcomes in this study were the incidence of symptoms consistent with JHR within 7 days after benzathine penicillin G treatment. Unelicited and elicited symptoms were assessed by participant self-report using a standardized checklist during contact made by a study clinician. Factors associated with JHR were collected at baseline, and serologic treatment response was assessed at 6 months. Posttreatment incident JHR symptoms were captured as safety outcomes for this trial. Analysis was performed on an intention-to-treat basis.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 249 participants, the median age was 32 years (IQR, 27-41 years), 242 (97.2%) were men, and 153 (61.4%) were living with HIV. One or more JHR symptoms occurred in 59 participants (23.7%) treated for early syphilis, with a median symptom onset at 4.9 hours (IQR, 3.0-9.2 hours) and a median duration of 12.8 hours (IQR, 5.0-24.0 hours). Symptom onset was within 12 hours of treatment for 49 of 57 participants (86.0%). Among 59 symptomatic participants, myalgias (30 [50.8%]), chills (27 [45.8%]), weakness (23 [39.0%]), and feverishness (21 [35.6%]) were most common. In adjusted models, JHR was associated with secondary syphilis (adjusted odds ratio [AOR], 2.91 [95% CI, 1.51-5.61]) and the absence of HIV (AOR for living with HIV, 0.49 [95% CI, 0.26-0.94]). The proportion of participants with a serologic treatment response to benzathine penicillin G at 6 months was higher among participants with JHR (84.7% [50 of 59] vs 68.9% [131 of 190] without JHR).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this prespecified secondary analysis of a randomized clinical trial of early syphilis treatment wtih benzathine penicillin G in adults, approximately 1 in 4 participants experienced short-lived JHR symptoms, which were associated with secondary syphilis stage, lack of HIV, and successful treatment outcomes at 6 months. These messages could be used in patient counseling.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03637660<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.59490","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:11:01Z","timestamp":1739463061000},"page":"e2459490","source":"Crossref","is-referenced-by-count":9,"title":["Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment in Adults With Early Syphilis"],"prefix":"10.1001","volume":"8","author":[{"given":"Jodie A.","family":"Dionne","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Emmes Company LLC, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mejia-Galvis","sequence":"additional","affiliation":[{"name":"Enteric and Sexually Transmitted Infections Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Workowski","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Batteiger","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Dombrowski","sequence":"additional","affiliation":[{"name":"Division of Allergy and Infectious Diseases, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"},{"name":"Department of Medicine, Beth Israel Deaconess Medical Center\/Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice J.","family":"McNeil","sequence":"additional","affiliation":[{"name":"Section on Infectious Diseases, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene C.","family":"Se\u00f1a","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Taylor","sequence":"additional","affiliation":[{"name":"Section on Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold C.","family":"Wiesenfeld","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Hamill","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Perlowski","sequence":"additional","affiliation":[{"name":"FHI 360, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Edward W.","family":"Hook","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"zoi241658r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2013.04.001","author":"Belum","year":"2013","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"zoi241658r2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/infdis\/133.6.696","article-title":"Clinical pathology of the Jarisch-Herxheimer reaction.","volume":"133","author":"Bryceson","year":"1976","journal-title":"J Infect Dis"},{"issue":"2, pt 1","key":"zoi241658r3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0190-9622(95)90136-1","article-title":"From mercury to malaria to penicillin: the history of the treatment of syphilis at the Mayo Clinic\u20141916-1955.","volume":"32","author":"Sartin","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"zoi241658r4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059266","article-title":"The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.","volume":"8","author":"Guerrier","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"zoi241658r5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/2325957417702484","article-title":"The first report of Bartonella quintana immune reconstitution inflammatory syndrome complicated by Jarisch-Herxheimer reaction.","volume":"16","author":"DallaPiazza","year":"2017","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"3","key":"zoi241658r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008656","article-title":"Louse-borne relapsing fever\u2014a systematic review and analysis of the literature, part 2: mortality, Jarisch-Herxheimer reaction, impact on pregnancy.","volume":"15","author":"Kahlig","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"zoi241658r7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis.","volume":"96","author":"Butler","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"zoi241658r8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1258\/ijsa.2010.010281","article-title":"Jarisch-Herxheimer reaction among syphilis patients in Rio de Janeiro, Brazil.","volume":"21","author":"Miller","year":"2010","journal-title":"Int J STD AIDS"},{"issue":"3, pt 1","key":"zoi241658r9","first-page":"375","article-title":"The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy.","volume":"75","author":"Klein","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi241658r10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/infdis\/146.5.606","article-title":"Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin.","volume":"146","author":"Young","year":"1982","journal-title":"J Infect Dis"},{"issue":"5","key":"zoi241658r11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJM199608013350503","article-title":"Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor a.","volume":"335","author":"Fekade","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi241658r12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/sti.57.4.226","article-title":"Jarisch-Herxheimer reaction in complement-depleted rabbits: histological and immunofluorescence studies of early cutaneous lesions.","volume":"57","author":"Aronson","year":"1981","journal-title":"Br J Vener Dis"},{"issue":"3","key":"zoi241658r13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00002018-199512030-00004","article-title":"Antibiotic-induced release of endotoxin: a therapeutic paradox.","volume":"12","author":"Hurley","year":"1995","journal-title":"Drug Saf"},{"key":"zoi241658r14","doi-asserted-by":"publisher","DOI":"10.1086\/656419","author":"Yang","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi241658r15","doi-asserted-by":"publisher","first-page":"18993","DOI":"10.7448\/IAS.17.1.18993","article-title":"Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy.","volume":"17","author":"Tsai","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"zoi241658r16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jama.1948.02900070012003","article-title":"Jarisch-Herxheimer reaction in early syphilis treated with crystalline penicillin G.","volume":"138","author":"Farmer","year":"1948","journal-title":"JAMA"},{"issue":"3","key":"zoi241658r17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2310\/7750.2009.09009","article-title":"The green monster: Stokes\u2019s 1944 Modern Clinical Syphilology.","volume":"14","author":"Jackson","year":"2010","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"zoi241658r18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cir671","article-title":"Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis.","volume":"53","author":"Se\u00f1a","year":"2011","journal-title":"Clin Infect Dis"},{"key":"zoi241658r19","doi-asserted-by":"publisher","journal-title":"Open Forum Infect Dis","DOI":"10.1093\/ofid\/ofad500.2472"},{"issue":"10","key":"zoi241658r20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/jdv.15078","article-title":"The Jarisch-Herxheimer reaction in syphilis: could molecular typing help to understand it better?","volume":"32","author":"Arando","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"zoi241658r21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/jog.15583","article-title":"The incidence of Jarisch-Herxheimer reactions and associated risk factors in pregnant women and nonpregnant women: a retrospective chart review at a university hospital in Japan.","volume":"49","author":"Mori","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"issue":"8","key":"zoi241658r22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jama.1927.02680340061033","volume":"88","year":"1927","journal-title":"JAMA"},{"issue":"9","key":"zoi241658r23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJMra1901593","article-title":"The modern epidemic of syphilis.","volume":"382","author":"Ghanem","year":"2020","journal-title":"N Engl J Med"},{"key":"zoi241658r24","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1038\/nrdp.2017.73","article-title":"Syphilis.","volume":"3","author":"Peeling","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"zoi241658r25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4049\/jimmunol.124.1.461","article-title":"Characterization of lymphocyte responsiveness in early experimental syphilis, II: nature of cellular infiltration and Treponema pallidum distribution in testicular lesions.","volume":"124","author":"Lukehart","year":"1980","journal-title":"J Immunol"},{"issue":"6","key":"zoi241658r26","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1128\/IAI.01973-06","article-title":"CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.","volume":"75","author":"Leader","year":"2007","journal-title":"Infect Immun"},{"issue":"8","key":"zoi241658r27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/sextrans-2016-053083","article-title":"Unique manifestations and risk factors of Jarisch-Herxheimer reaction during treatment of child congenital syphilis.","volume":"94","author":"Wang","year":"2018","journal-title":"Sex Transm Infect"},{"issue":"6","key":"zoi241658r28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/OLQ.0000000000001950","article-title":"HIV infection modifies the role of prior Treponema pallidum infection in the clinical presentation of early syphilis among adult patients from sexually transmitted infection clinics in Peru.","volume":"51","author":"Reyes-Diaz","year":"2024","journal-title":"Sex Transm Dis"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2830226\/dionne_2025_oi_241658_1738862589.59425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:11:05Z","timestamp":1739463065000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2830226"}},"subtitle":["Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.59490","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}